In committing to the Open COVID Pledge, which originated in the US, Fujitsu has declared that it will not assert its patents, utility models, or designs against individuals or entities for a certain period of time and will not seek any consideration or compensation for such activities. Fujitsu has also endorsed and declared its involvement with the “OPEN COVID-19 DECLARATION,” a similar initiative in Japan.
Through its commitment to these pledges, Fujitsu will contribute decisively to an early end to the spread of the COVID-19 pandemic by providing free access to approximately 40,000 patents, utility models, design patents (including pending applications) related to the development of new drugs and patient care, and actively promote cross-industry utilization by companies and research institutions around the world in the spirit of global cooperation and human-centric innovation.
